VIEWPOINTS PharmaShots Interview: Diffusion’s Dr. Bob Cobuzzi Shares Insights on the Trans Sodium Crocetinate (TSC) to Improve HypoxiaBySenior EditorNovember 3, 20210Comments
VIEWPOINTS PharmaShots Interview: BioCorRx’ Brady Granier Shares Insights on the New Agreement with Recro to Support BICX104BySenior EditorNovember 2, 20210Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Dr. Briggs W. Morrison of Syndax Share Insight on the Syndax’ Agreement with Incyte for AxatilimabBySenior EditorNovember 1, 20210Comments
VIEWPOINTS PharmaShots Interview: Astellas’ Txema Sanz Shares Insights on the Evrenzo (roxadustat) for Symptomatic Anemia Associated with Chronic Kidney DiseaseBySenior EditorOctober 27, 20210Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Jonathan Benjamin of Atreca Share Insight on the Data of ATRC-101 to Treat Solid TumorBySenior EditorOctober 22, 20210Comments
VIEWPOINTS PharmaShots Interview: Accenture’s Rich Birhanzel Shares Insight on the Investment in ixlayerBySenior EditorOctober 22, 20210Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in September 2021BySenior EditorOctober 21, 20210Comments
VIEWPOINTS PharmaShots Interview: Cue Biopharma’s Anish Suri Shares Insights on the Data of CUE-401 Presented at 2021 FOCIS Annual MeetingBySenior EditorOctober 15, 20210Comments
